OKUR
OnKure Therapeutics, Inc.
NASDAQ: OKUR · HEALTHCARE · BIOTECHNOLOGY
$3.44
-12.02% today
Updated 2026-05-11
Market cap
$157.95M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$2 – $5
Volume
0.3M
OnKure Therapeutics, Inc. (OKUR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-18.54M | $-37.98M | $-26.95M | $-34.55M | $-51.12M | $-51.83M |
| Capital expenditures | $24000.00 | $198000.00 | $1.13M | $246000.00 | $52000.00 | $46000.00 |
| Depreciation | $37000.00 | $50000.00 | $387000.00 | $560000.00 | $662000.00 | — |
| Stock-based comp | — | — | $48000.00 | $199000.00 | $4.53M | $11.63M |
| Free cash flow | $-18.56M | $-38.18M | $-28.09M | $-34.79M | $-51.17M | $-51.87M |
| Investing cash flow | $7.38M | $-23.38M | $-1.13M | $-246000.00 | $15.87M | — |
| Financing cash flow | $47.27M | $132.41M | $26.46M | $53.13M | $116.13M | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |